Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding COVID-19 Vaccines in Children
In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee, Public Citizen agreed with the need for an Emergency Use Authorization for the Moderna-NIH COVID-19 vaccine for in adolescents aged 12-17 years.
See Public Citizen’s other work on the coronavirus pandemic.